siRNA therapy reduces triglycerides in individuals along with rare condition

.RESEARCH HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride levels through 80% and also reduced the danger of pancreatitis in clients along with consistent chylomicronemia, along with or even without a genetic prognosis.